Literature DB >> 17307133

Cellular and molecular effects of unoprostone as a BK channel activator.

John Cuppoletti1, Danuta H Malinowska, Kirti P Tewari, Jayati Chakrabarti, Ryuji Ueno.   

Abstract

Effects of unoprostone isopropyl (unoprostone), a prostaglandin metabolite analog; latanoprost, a PGF(2alpha) analog; and PGF(2alpha) were examined in HCN-1A cells, a model system for studies of large conductance Ca(2+) activated K(+)(BK) channel activator-based neuroprotective agents. Unoprostone and latanoprost, both used as anti-glaucoma agents, have been suggested to act through FP receptors and have neuroprotective effects. Ion channel activation, plasma membrane polarization, [Ca(2+)](i) changes and protection against long-term irreversible glutamate-induced [Ca(2+)](i) increases were studied. Unoprostone activated iberiotoxin (IbTX)-sensitive BK channels in HCN-1A cells with an EC(50) of 0.6+/-0.2 nM and had no effect on Cl(-) currents. Unoprostone caused IbTX-sensitive plasma membrane hyperpolarization that was insensitive to AL8810, an FP receptor antagonist. In contrast, latanoprost and PGF(2alpha) activated a Cl(-) current sensitive to [Ca(2+)](i) chelation, tamoxifen and AL8810, and caused IbTX-insensitive, AL8810-sensitive membrane depolarization consistent with FP receptor-mediated Ca(2+) signaling Cl(-) current activation. Latanoprost and PGF(2alpha), but not unoprostone, increased [Ca(2+)](i). Unoprostone, PGF(2alpha) only partially, but not latanoprost protected HCN-1A cells against glutamate-induced Ca(2+) deregulation. These findings show that unoprostone has a distinctly different mechanism of action from latanoprost and PGF(2alpha). Whether unoprostone affects the BK channel directly or an unidentified signaling mechanism has not been determined.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307133     DOI: 10.1016/j.bbamem.2006.12.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  Unoprostone activation of BK (KCa1.1) channel splice variants.

Authors:  Ling Yu; Amity F Eaton; Qiang Yue; Hui-Fang Bao; He-Ping Ma; John Cuppoletti; Douglas C Eaton
Journal:  Biochim Biophys Acta       Date:  2015-08-13

2.  Regeneration of optic nerve fibers with unoprostone, a prostaglandin-related antiglaucoma drug, in adult cats.

Authors:  Hiroe Sagawa; Hiroko Terasaki; Keiko Nakanishi; Yoshihito Tokita; Masami Watanabe
Journal:  Jpn J Ophthalmol       Date:  2013-10-16       Impact factor: 2.447

Review 3.  Pharmacotherapy of glaucoma.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  J Ocul Pharmacol Ther       Date:  2015-01-14       Impact factor: 2.671

Review 4.  BK Channels in the Central Nervous System.

Authors:  C Contet; S P Goulding; D A Kuljis; A L Barth
Journal:  Int Rev Neurobiol       Date:  2016-05-13       Impact factor: 3.230

Review 5.  Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma.

Authors:  Peter G Klimko; Najam A Sharif
Journal:  Br J Pharmacol       Date:  2018-05-17       Impact factor: 8.739

6.  Physicochemical and biological characterization of sustained isopropyl unoprostone-release device made of poly(ethyleneglycol) dimethacrylates.

Authors:  Nobuhiro Nagai; Yasuko Izumida; Yoshimasa Yamazaki; Hirokazu Kaji; Junichi Kawasaki; Matsuhiko Nishizawa; Toshiaki Abe
Journal:  J Mater Sci Mater Med       Date:  2017-05-22       Impact factor: 3.896

Review 7.  Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.

Authors:  Najam A Sharif; Peter G Klimko
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

8.  PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia.

Authors:  Sofiyan Saleem; Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2009-02-11       Impact factor: 3.911

9.  Enhanced conversion of induced neuronal cells (iN cells) from human fibroblasts: Utility in uncovering cellular deficits in mental illness-associated chromosomal abnormalities.

Authors:  Eleonora Passeri; Ashley M Wilson; Amedeo Primerano; Mari A Kondo; Srona Sengupta; Rupali Srivastava; Minori Koga; Cassandra Obie; Peter P Zandi; Fernando S Goes; David Valle; Judith L Rapoport; Akira Sawa; Shin-ichi Kano; Koko Ishizuka
Journal:  Neurosci Res       Date:  2015-08-07       Impact factor: 3.304

10.  Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients.

Authors:  Ciro Caruso; Luigi Pacente; Pasquale Troiano; Carmine Ostacolo; Luca D'Andrea; Silvia Bartollino; Ciro Costagliola
Journal:  Int Ophthalmol       Date:  2019-12-03       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.